Frequency of acute kidney injury following intravenous contrast medium administration: A systematic review and meta-analysis

Radiology

Volumn 267, Issue 1, 2013, Pages 119-128

  McDonald, Jennifer S ^a   McDonald, Robert J ^a   Comin, Jules ^b   Williamson, Eric E ^a   Katzberg, Richard W ^c   Murad, M Hassan ^a   Kallmes, David F ^a  

^a MAYO CLINIC   (United States)

^b ST VINCENT S HOSPITAL   (Australia)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; CREATININE; GADOLINIUM;

ACUTE KIDNEY FAILURE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST INDUCED NEPHROPATHY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FAILURE; META ANALYSIS; NEPHROTOXICITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; REVIEW; RISK ASSESSMENT; RISK FACTOR; SIDE EFFECT; SYSTEMATIC REVIEW;

CONTRAST MEDIA; DIAGNOSTIC IMAGING; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY DISEASES;

EID: 84875410288     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.12121460     Document Type: Review

References (55)

1. Katzberg RW. Contrast-induced nephropathy in 2010. Appl Radiol 2010;39(09):21-23.
2. Barrett BJ, Parfrey PS. Clinical practice. Preventing nephropathy induced by contrast medium. N Engl J Med 2006;354(4):379- 386.
3. Gleeson TG, Bulugahapitiya S. Contrastinduced nephropathy. AJR Am J Roentgenol 2004;183(6):1673-1689.
4. McCullough PA, Adam A, Becker CR, et al. Risk prediction of contrast-induced nephropathy. Am J Cardiol 2006;98(6A):27K- 36K.
5. McCullough PA, Wolyn R, Rocher LL, Levin RN, O'Neill WW. Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. Am J Med 1997;103(5):368-375.
6. Solomon R, Dumouchel W. Contrast media and nephropathy: findings from systematic analysis and Food and Drug Administration reports of adverse effects. Invest Radiol 2006; 41(8):651-660.
7. Tepel M, Aspelin P, Lameire N. Contrastinduced nephropathy: a clinical and evidence- based approach. Circulation 2006; 113(14):1799-1806.
8. Stacul F, van der Molen AJ, Reimer P, et al. Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines. Eur Radiol 2011;21(12):2527-2541.
9. Benko A, Fraser-Hill M, Magner P, et al. Canadian Association of Radiologists: consensus guidelines for the prevention of contrast-induced nephropathy. Can Assoc Radiol J 2007;58(2):79-87.
10. ACR Manual on Contrast Media. Version 7 2010. http://www.nxtbook.com/ nxtbooks/arrs/contrastmediamanual2010/. Published 2010. Accessed June 17, 2012.
11. Katzberg RW, Newhouse JH. Intravenous contrast medium-induced nephrotoxicity: is the medical risk really as great as we have come to believe? Radiology 2010;256(1):21-28.
12. Katzberg RW, Pabico RC, Morris TW, et al. Effects of contrast media on renal function and subcellular morphology in the dog. Invest Radiol 1986;21(1):64-70.
13. Stratta P, Bozzola C, Quaglia M. Pitfall in nephrology: contrast nephropathy has to be differentiated from renal damage due to atheroembolic disease. J Nephrol 2012; 25(3):282-289.
14. Canavese C, Morra F, Morellini V, et al. How can we be sure that renal dysfunction after coronary angiography is just explained by contrast nephropathy? [letter]. Kidney Int 2004;66(4):1717; author reply. 1717-1718.
15. Solomon R. Contrast-induced acute kidney injury: is there a risk after intravenous contrast? Clin J Am Soc Nephrol 2008;3(5): 1242-1243.
16. Ellis JH, Cohan RH. Reducing the risk of contrast-induced nephropathy: a perspective on the conroversies. AJR Am J Roentgenol 2009;192(6):1544-1549.
17. Idée JM, Bonnemain B. Reliability of experimental models of iodinated contrast mediainduced acute renal failure: from methodological considerations to pathophysiology. Invest Radiol 1996;31(4):230-241.
18. Katzberg RW. What do we really know about contrast medium-induced acute renal failure? Invest Radiol 1989;24(3):219-220.
19. Gomes AS, Baker JD, Martin-Paredero V, et al. Acute renal dysfunction after major arteriography. AJR Am J Roentgenol 1985;145(6):1249-1253.
20. Katzberg RW, Barrett BJ. Risk of iodinated contrast material - induced nephropathy with intravenous administration. Radiology 2007; 243(3):622-628.
21. Mudge GH. Nephrotoxicity of urographic radiocontrast drugs. Kidney Int 1980;18(5): 540-552.
22. Solomon R, Briguori C, Bettmann M. Selection of contrast media. Kidney Int Suppl 2006 (suppl 100):S39-S45.
23. Baumgarten DA, Ellis JH. Contrast-induced nephropathy: contrast material not required? AJR Am J Roentgenol 2008;191(2): 383-386.
24. Stanley K. Design of randomized controlled trials. Circulation 2007;115(9):1164-1169.
25. Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol 2009;62(10):1006-1012.
26. Wells G, Shea B, O'Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in metaanalyses. http://www.ohri.ca/programs/clinical-epidemiology/oxford.asp. Published 2011. Accessed June 17, 2012.
27. Borenstein M. Introduction to meta-analysis. Chichester, England: Wiley, 2009.
28. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7(3): 177-188.
29. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in metaanalyses. BMJ 2003;327(7414):557-560.
30. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002;39(2 suppl 1): S1-S266.
31. Altman DG, Bland JM. Interaction revisited: the difference between two estimates [letter]. BMJ 2003;326(7382):219.
32. Jakobsen JA, Berg KJ, Waaler A, Andrew E. Renal effects of the non-ionic contrast medium iopentol after intravenous injection in healthy volunteers. Acta Radiol 1990;31(1):87-91.
33. Janousek R, Krajina A, Peregrin JH, et al. Effect of intravascular iodinated contrast media on natural course of end-stage renal disease progression in hemodialysis patients: a prospective study. Cardiovasc Intervent Radiol 2010;33(1):61-66.
34. Muntner P, Coresh J, Klag MJ, Whelton PK, Perneger TV. Exposure to radiologic contrast media and an increased risk of treated end-stage renal disease. Am J Med Sci 2003;326(6):353-359.
35. Schild HH, Kuhl CK, Hübner-Steiner U, Böhm I, Speck U. Adverse events after unenhanced and monomeric and dimeric contrast- enhanced CT: a prospective randomized controlled trial. Radiology 2006;240(1): 56-64.
36. Parfrey PS, Griffiths SM, Barrett BJ, et al. Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both: a prospective controlled study. N Engl J Med 1989;320(3):143-149.
37. Mojtahedzadeh M, Sabzghabaee AM, Ganji MR, Razavi P. Risk factors and prognostic factors of acute renal failure in patients admitted to an intensive care unit, Tehran-Iran. Iran J Pharmacol Ther 2009;8(2):87-91.
38. Aulicky P, Mikulík R, Goldemund D, Reif M, Dufek M, Kubelka T. Safety of performing CT angiography in stroke patients treated with intravenous thrombolysis. J Neurol Neurosurg Psychiatry 2010;81(7):783-787.
39. Bansal GJ, Darby M. Measurement of change in estimated glomerular filtration rate in patients with renal insufficiency after contrast-enhanced computed tomography: a case-control study. J Comput Assist Tomogr 2009;33(3):455-459.
40. Bruce RJ, Djamali A, Shinki K, Michel SJ, Fine JP, Pozniak MA. Background fluctuation of kidney function versus contrast-induced nephrotoxicity. AJR Am J Roentgenol 2009;192(3):711-718.
41. Cramer BC, Parfrey PS, Hutchinson TA, et al. Renal function following infusion of radiologic contrast material: a prospective controlled study. Arch Intern Med 1985;145(1):87-89.
42. Heller CA, Knapp J, Halliday J, O'Connell D, Heller RF. Failure to demonstrate contrast nephrotoxicity. Med J Aust 1991;155(5): 329-332.
43. Heller M, Husk G, Bowers W, et al. Contrast CT scans in the emergency department: is there really an increased risk of adverse clinical outcomes? [abstr]. Acad Emerg Med 2011;(1):S231.
44. Langner S, Stumpe S, Kirsch M, Petrik M, Hosten N. No increased risk for contrast-induced nephropathy after multiple CT perfusion studies of the brain with a nonionic, dimeric, iso-osmolal contrast medium. AJNR Am J Neuroradiol 2008;29(8):1525-1529.
45. Lima FO, Lev MH, Levy RA, et al. Functional contrast-enhanced CT for evaluation of acute ischemic stroke does not increase the risk of contrast-induced nephropathy. AJNR Am J Neuroradiol 2010;31(5):817- 821.
46. McGillicuddy EA, Schuster KM, Kaplan LJ, et al. Contrast-induced nephropathy in elderly trauma patients. J Trauma 2010; 68(2):294-297. [Published correction appears in J Trauma 2010;68(4):998.]
47. Ng CS, Shaw AD, Bell CS, Samuels JA. Effect of IV contrast medium on renal function in oncologic patients undergoing CT in ICU. AJR Am J Roentgenol 2010;195(2):414-422.
48. Oleinik A, Romero JM, Schwab K, et al. CT angiography for intracerebral hemorrhage does not increase risk of acute nephropathy. Stroke 2009;40(7):2393-2397.
49. Polena S, Yang S, Alam R, et al. Nephropathy in critically ill patients without preexisting renal disease. Proc West Pharmacol Soc 2005;48:134-135.
50. Tremblay LN, Tien H, Hamilton P, et al. Risk and benefit of intravenous contrast in trauma patients with an elevated serum creatinine. J Trauma 2005;59(5):1162-1166; discussion 1166-1167.
51. Rao QA, Newhouse JH. Risk of nephropathy after intravenous administration of contrast material: a critical literature analysis. Radiology 2006;239(2):392-397.
52. McCullough PA, Adam A, Becker CR, et al. Epidemiology and prognostic implications of contrast-induced nephropathy. Am J Cardiol 2006;98(6A):5K-13K.
53. Davidson C, Stacul F, McCullough PA, et al. Contrast medium use. Am J Cardiol 2006; 98(6A):42K-58K.
54. Newhouse JH, Kho D, Rao QA, Starren J. Frequency of serum creatinine changes in the absence of iodinated contrast material: implications for studies of contrast nephrotoxicity. AJR Am J Roentgenol 2008; 191(2):376-382.
55. Lau J, Ioannidis JP, Terrin N, Schmid CH, Olkin I. The case of the misleading funnel plot. BMJ 2006;333(7568):597-600.